Wealth manager Stephen Jones, who rode all 21 stages of the 2015 Tour de France route in July in aid of Cure Leukaemia, has raised an additional £10,000 for the charity after a celebratory dinner in Dorridge, Solihull.
The father of two, who works for national wealth management firm Brewin Dolphin, joined former England, Crystal Palace and Wolverhampton Wanderers footballer and Cure Leukaemia Patron, Geoff Thomas, on ‘Le Tour – One Day Ahead’ with nine other cyclists. These amateurs took on the full Tour de France route, a day before the likes of Chris Froome.
Stephen, 53, from Solihull, had already raised a staggering £70,000 for Cure Leukaemia but wanted to continue the fundraising by holding a celebratory dinner for friends, colleagues and fellow riders at the Forest Hotel, Dorridge. Blood cancer survivor Geoff and fellow riders James Maltin, of Rathbones in London, Melissa Brand, who works at the Solihull office of Prologis, and Sigma Director Doug McKinnon all attended and entertained guests with stories from their epic experience.
With a raffle and auction, the evening was a great success and Stephen was delighted to raise another £10,000 for the cause.
“I’m thrilled the evening was a success. The guests enjoyed hearing about this phenomenal experience I was honoured to be a part of.
Having met Professor Charlie Craddock, the co-founder of Cure Leukaemia, and some of the patients currently battling blood cancer, I know how important this charity is for not only the Midlands but also for the global fight against this terrible disease.”
CEO of Cure Leukaemia, James McLaughlin, who also attended the dinner, said:
“We are all in awe of what Stephen has achieved, not only in completing one of the toughest physical challenges in world sport but also with his phenomenal fundraising efforts. The money he has raised is worth ten times that value in potentially life-saving treatments for people battling this terrible disease.
These funds will help save lives. We cannot be more grateful for what Stephen has done for Cure Leukaemia.”
Cure Leukaemia's £1m Centre Appeal 2017